European Journal of NeuroscienceNeurosciencePeer-reviewed journal article
Amyloid-beta pathology increases synaptic engulfment by glia in feline cognitive dysfunction syndrome: A naturally occurring model of Alzheimer's disease
Robert I. McGeachaniD, Lucy Ewbank, Meg Watt, Lorena SordoiD, Alexandra J. MalboniD, Muhammad Khalid Farooq SalamatiD, Makis TziorasiD, João Miguel De FriasiD, Jane TullochiD, Fiona E. HoustoniD, Danièlle Audry Gunn-MooreiD, Tara L. Spires‐JonesiD
Abstract
Feline cognitive dysfunction syndrome (CDS) is an age-related neurodegenerative disorder, comparable to dementia in people, characterised by behavioural changes such as increased vocalisation, altered social interactions, sleep-wake cycle, disorientation and house-soiling. Although the underlying mechanisms remain poorly understood, pathologies similar to those observed in Alzheimers disease (AD), have been identified in the brains of aged or CDS-affected cats, including brain atrophy, neuronal loss, amyloid-beta plaques, tau pathology, and cerebral amyloid angiopathy. Neuroinflammation and synapse loss, other important hallmarks of AD, may also play important roles in feline ageing and CDS, but these are yet to be explored. Several mechanisms of synapse loss have been described in human AD and mouse models of amyloidopathy, including synaptic accumulation of amyloid-beta, and the aberrant induction of synaptic engulfment by microglia and astrocytes. In this study, immunohistochemistry and confocal microscopy were used to examine the parietal cortex of young (n=7), aged (n=10), and CDS-affected (n=8) cats. Linear mixed effect modelling revealed that amyloid-beta accumulates within synapses in the aged and CDS-affected brain. Additionally, in the aged and CDS groups there was microgliosis, astrogliosis and increased synaptic engulfment by microglia and astrocytes in regions with A{beta} plaques. Further, microglia and astrocytes show increased internalisation of amyloid-beta-containing synapses near plaques. These findings suggest that amyloid-beta exerts a pathogenic effect in the feline brain, with mechanisms mirroring those seen in human AD.
- Citations
- 8
- FWCI
- 5.11
- Field percentile
- top 4%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Activated gliosis, accumulation of amyloid beta and hyperphosphorylation of tau in aging canines with and without cognitive decline
Amelia D. Hines, Stephanie McGrath, … Julie A. Moreno·Frontiers in Aging NeurosciencePeer-reviewed·Apr 27, 2023
- Young adult microglial deletion of C1q reduces engulfment of synapses and prevents cognitive impairment in an aggressive Alzheimer's disease mouse model
Tiffany J. Petrisko, Shu‐Hui Chu, … Andrea J. Tenner·bioRxiv·Sep 13, 2025
- Complement component C4 regulates amyloid pathology and glial reactivity in mouse model of Alzheimer's Disease
Collin J. Nadarajah, Michelle Y. Li, … Erik S. Musiek·bioRxiv·Sep 10, 2026
- Human astrocytes and microglia show augmented ingestion of synapses in Alzheimer's disease via MFG-E8
Makis Tzioras, Michael J. D. Daniels, … Tara L. Spires‐Jones·Cell Reports MedicinePeer-reviewed·Aug 30, 2023
- Astrocyte-derived MFG-E8 facilitates microglial synapse elimination in Alzheimer's disease mouse models
Dimitra Sokolova, Shari Addington Ghansah, … Soyon Youngae Hong·bioRxiv·Aug 31, 2024
- Inhibition of cathepsin B blocks amyloidogenesis in the mouse models of neurological lysosomal diseases mucopolysaccharidosis type IIIC and sialidosis
Gustavo Monteiro Viana, Xuefang Pan, … Alexey V. Pshezhetsky·Molecular Therapy — Methods & Clinical DevelopmentPeer-reviewed·Feb 11, 2025